Micromem Advances Liquid-Phase Nanowire Sensor Toward Medical and Defence Markets

Micromem Technologies ( (TSE:MRM) ) has shared an announcement.

Micromem Technologies has reported significant progress in its liquid-phase sensor program under a research collaboration with the University of Toronto and Canada’s Department of National Defence, advancing a nanowire field-effect transistor platform for biochemical detection. The technology has successfully detected clinically relevant biomarkers linked to acute inflammation and infectious disease, confirming high sensitivity and supporting the transition toward integrated, portable microfluidic systems.

Recent achievements include new on-chip electrode designs, improved NWFET fabrication and photolithography processes, and successful tests on biomarkers such as angiopoietin-1 and TREM-1 at low concentrations. The liquid-phase program, alongside Micromem’s parallel gas-phase sensor work, expands the company’s addressable market from defence-focused threat detection into commercial medical diagnostics and point-of-care testing, potentially enhancing its long-term platform value and reinforcing its dual-use strategy for defence and healthcare stakeholders.

The most recent analyst rating on (TSE:MRM) stock is a Hold with a C$0.03 price target. To see the full list of analyst forecasts on Micromem Technologies stock, see the TSE:MRM Stock Forecast page.

Spark’s Take on MRM Stock

According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.

The score is driven down primarily by very weak financial performance (no revenue, persistent losses/cash burn, negative equity and high leverage vs. assets). Technicals are also weak with the stock below major moving averages, while valuation is constrained by negative earnings and no dividend. Recent financings provide some liquidity support but reinforce ongoing funding and dilution risk.

To see Spark’s full report on MRM stock, click here.

More about Micromem Technologies

Micromem Technologies Inc. is a publicly traded sensor-technology company that develops intelligent applications for sectors including oil and gas, utilities, automotive, healthcare, government, information technology, and manufacturing. The company focuses on sophisticated sensor-based solutions that address unmet market needs, often translating advanced research collaborations into scalable commercial products.

Average Trading Volume: 85,598

Technical Sentiment Signal: Sell

Current Market Cap: C$21.48M

For detailed information about MRM stock, go to TipRanks’ Stock Analysis page.